key: cord-0766102-i934doud
authors: PONNAPA REDDY, M.; SUBRAMANIAM, A.; LIM, Z. J.; ZUBAREV, A.; AFROZ, A.; BILLAH, B.; TIRUVOIPATI, R.; RAMANATHAN, K.; WONG, S. N.; BRODIE, D.; FAN, E.; SHEKAR, K.
title: Prone positioning of non-intubated patients with COVID-19 - A Systematic Review and Meta-analysis
date: 2020-10-14
journal: nan
DOI: 10.1101/2020.10.12.20211748
sha: 2fa3203c6a549213abc1dd8c5956b8abe3c2e8de
doc_id: 766102
cord_uid: i934doud

Purpose: Several studies have reported adopting prone positioning (PP) in non-intubated patients with COVID-19-related hypoxaemic respiratory failure. This systematic review and meta-analysis evaluated the impact of PP on oxygenation and clinical outcomes. Methods: We searched PubMed, Embase and COVID-19 living systematic review from December1st 2019 to July23rd 2020. We included studies that reported using PP in hypoxaemic, non-intubated adult COVID-19 patients. Primary outcome measure was the weighted mean difference (MD) in oxygenation parameters (PaO2/FiO2, PaO2 or SpO2) pre and post-PP. Results: Fifteen single arm observational studies reporting PP in 449 patients were included. Substantial heterogeneity was noted in terms of, location within hospital where PP was instituted, respiratory supports, frequency and duration of PP. Significant improvement in oxygenation was reported post-PP: PaO2/FiO2, (MD 37.6, 95%CI 18.8, 56.5); PaO2, , (MD 30.4 mmHg, 95%CI 10.9, 49.9); and SpO2, (MD 5.8%, 95%CI 3.7, 7.9). Patients with a pre-PP PaO2/FiO2 [≤]150 experienced greater oxygenation improvements compared with those with a pre-PP PaO2/FiO2 >150 (MD 40.5, 95%CI -3.5, 84.6) vs. 37, 95%CI 17.1, 56.9). Respiratory rate decreased post-PP (MD -2.9, 95%CI -5.4, -0.4). Overall intubation and mortality rates were 21% (90/426) and 26% (101/390) respectively. No major adverse events were reported. Conclusions: Despite significant variability in frequency and duration of PP and respiratory supports, PP was associated with improvements in oxygenation parameters without any reported serious adverse events. Major limitation being lack of control arm and adjustment for confounders. Clinical trials are required to determine the effect of awake PP on patient-centred outcomes.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. . https://doi.org/10.1101/2020. 10.12.20211748 doi: medRxiv preprint

Coronavirus disease 2019 , caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly affects the respiratory system and can lead to acute hypoxaemic respiratory failure. 0.9% to 32% of these patients require admission to intensive care units (ICU) for advanced respiratory support. [1] [2] [3] [4] A surge in critically ill patients with respiratory failure has overwhelmed ICU capacity in many healthcare systems across the world. Studies published during the early phase of the pandemic have showed poor outcomes in invasively ventilated COVID-19 patients. Given a guarded prognosis and significant resource constraints less-invasive, innovative approaches such as prone positioning (PP) of non-intubated patients with hypoxaemic respiratory failure was considered. They were initiated in emergency departments (ED), hospital wards, or in ICUs as an adjunct to conventional oxygen therapies, high-flow nasal cannula (HFNC) and non-invasive ventilation (NIV). 5 6 The potential efficacy of PP with hypoxaemic respiratory failure is yet to be meaningfully tested in welldesigned clinical trials. Limited data suggests that PP in non-intubated patients is feasible and is associated with an improvement in oxygenation in patients with respiratory failure. 7 There have been case reports and cohort studies that report the use of PP of non-intubated patients with COVID-19 during the pandemic. 2 8-10 Conceptually, awake PP is relatively less time and resource consuming as compared to PP in intubated patients. Theoretically, they may decrease the risks of adverse events seen in intubated prone patients.

Deteriorating oxygenation despite optimal less-invasive respiratory support 11 is one of the common triggers for invasive mechanical ventilation. PP improves oxygenation by increasing ventilationperfusion matching by the recruitment of the larger number of alveolar units located in dorsal areas of the lungs. 12 13 Furthermore, in patients with COVID-19, PP may also enable gravity assisted diversion of pulmonary blood flows to dorsal regions in the setting of pulmonary vascular dysregulation and loss of hypoxic pulmonary vasoconstriction response in selected patients. 14 Thus, the success of PP largely hinges on its ability to reliably and predictably improve oxygenation, which may then subsequently improve the respiratory drive, thereby decreasing the risk of self-inflicted lung injury or respiratory fatigue.

Little is known about the magnitude of the effect of PP on oxygenation and its ability to improve patientcentred outcomes in non-intubated COVID-19 patients. Therefore, we performed this systematic review and meta-analysis to evaluate the effect of PP on oxygenation parameters. Secondary analysis included rates of endotracheal intubation and in-hospital mortality.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted October 14, 2020. .

The protocol for this systematic review and meta-analysis was registered with PROSPERO (CRD42020194080). The study was conducted in adherence with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) Statement. 15

Studies on laboratory-confirmed SARS-CoV-2 hypoxaemic adult patients (≥18 years of age) requiring supplemental oxygen who received PP were included. Studies were excluded if (a) they were systematic reviews (b) they did not report on oxygenation parameters (either PaO 2 , SpO 2 or PaO 2/ FiO 2 ) (c) case reports or case series with fewer than 5 patients (to decrease reporting bias). The corresponding authors of a study were contacted for missing information required for the analysis.

Two authors (MR and AZ) independently searched on PubMed, Embase, Cochrane, Scopus and the COVID-19 living systematic review from December 1 st , 2019 to July 23 rd , 2020. COVID-19 living systematic review has a daily-updated list of pre-print and published articles relating to COVID-19 obtained from PubMed, EMBASE, medRxiv and bioRxiv. 16 The living systematic review was previously used during the Zika virus epidemic 17 and recently has been validated against an Ovid search relating to COVID-19 18 . Search terms were "Prone", "Prone Position*" or "Proning" along with "COVID-19"related terms were used within the title and abstract columns of the systematic review list. Our search was further supported by medical librarian search that was carried out independently (SW). A detailed search terms and tools are summarised in Supplementary Table 1 . No language restrictions were applied.

The Newcastle-Ottawa Scale (NOS) 19 was used to assess the quality of cohort studies while Joanna Briggs Institute Critical Appraisal Checklist 20 was used to evaluate case series. Using relevant appraisal tools, each study was objectively evaluated by two reviewers independently (MR and ZL). Any discrepancies in the approval scores were reviewed and resolved by an additional reviewer (AS) (Supplementary Table 2 ).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted October 14, 2020. . https://doi.org/10.1101/2020. 10.12.20211748 doi: medRxiv preprint The primary outcome was the change in oxygenation (i.e., PaO 2 /FiO 2 ratio, PaO 2 and SpO 2 ) following PP.

Different variables, such as the saturation of peripheral oxygen (SpO 2 ), the partial pressure of arterial oxygen (PaO 2 ), and the ratio of PaO 2 to the fraction of inspired oxygen (PaO 2 /FiO 2 ), have been used in the reported studies. We derived the PaO 2 from SpO 2 and vice versa if they were not reported in studies using the accepted conversion formulae for consistency to analyse the data (Supplementary Table 3 ). 21 For mall number of studies an estimation formula was used to convert median to mean values (Supplementary Table 4 ). 22 Median was derived for PaO 2 in 3 studies, for SPO 2 in 5 studies and for PaO 2 /FiO 2 in 2 studies. Sensitivity analyses for physiological parameters were performed by restricting to studies with sample sizes ≥ 20.

The secondary outcomes included endotracheal intubation rate and mortality. Major adverse events were defined as cardiac arrest, clinically significant haemodynamic instability or accidental dislodgment of intravenous line following PP. Further subgroup analyses were performed to compare: (1) the primary outcome between patients with pre-PP PaO 2 /FiO 2 >150 and PaO 2 /FiO 2 ≤ 150; and (2) the primary and secondary outcomes in patients depending on the location within hospital where PP was initiated (within ICU vs. outside ICU). We also performed an exploratory analysis on the changes in patients' respiratory rate (RR) after PP.

Statistical analyses were performed using the statistical software package Stata-Version 16 (Statacorp, USA). Mean (standard deviation [SD]) or median (interquartile range [IQR]) were used for numerical data and proportion for categorical data. We report weighted mean difference (MD) with 95% confidence intervals (95%-CI) for physiological parameters and event rates using a random effects model to account for both within-study and between-study variances. 23 Results were presented in Forest plots.

Heterogeneity was tested using the χ ² test on Cochran's Q statistic, which was calculated using H and I² indices. The I² index estimates the percentage of total variation across studies based on true betweenstudy differences rather than on chance. Conventionally, I 2 values of 0-25% indicate low heterogeneity, 26-75% indicate moderate heterogeneity, and 76-100% indicate substantial heterogeneity. 24 A subgroup analysis using different sample sizes was carried out to identify the possible causes of substantial heterogeneity. 24 Due to concerns of the limited available data we could not pre-specify the exact variables for subgroup analysis. Following data collection, we carried out two subgroup analyses on oxygenation and clinical outcomes-: ICU vs. non-ICU (emergency department [ED], respiratory wards, high dependency units [HDU] ) and baseline PaO 2 /FiO 2 ratio (PaO 2 /FiO 2 ≤ 150 and >150). Symmetry of the funnel plots was evaluated, and the Egger's regression test was used to examine for publication bias. 25 A p-value <0.05 was considered significant.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. . https://doi.org/10.1101/2020. 10.12.20211748 doi: medRxiv preprint From 248 studies we identified 15 eligible studies 2 9 10 26-37 and a total of 449 patients were included in the final analysis ( Figure 1 ) The 15 included studies are summarised in Table 1. The reports originated from 6 countries (China, France, Iran, Italy, USA and UK). 287 patients were men (63.9%) with a mean age (SD) of 56 (7) Table 5 ).

In the 420 patients for whom data on the location of provision of PP was available, 111 patients (26.4%) received PP in ICU and 309 (73.6%) outside ICU (respiratory wards, high dependency units or emergency departments).

The improvements in physiological parameters (PaO 2 /FiO 2 , PaO 2 , SpO 2 ) before and after PP are presented graphically in Figure 2 . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. There were no reported life-threatening or major adverse events following PP. Only reported minor events included pain in the back, sternum or scrotum; general discomfort, dyspnoea and coughing and confusion in a small number of patients. 26 36 37 Oxygenation outcomes were analysed based on the mean pre-PP PaO 2 /FiO 2 ≤ 150 (5 studies 10 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. 

This systematic review examined the effect of PP of non-intubated patients on oxygenation parameters in a heterogenous group of adult patients with COVID-19-related hypoxaemic respiratory failure. There was a significant improvement in oxygenation parameters (PaO 2 /FiO 2, PaO 2 and SpO 2 ) and respiratory rate upon PP. An improvement in these parameters was consistent, although there was significant variability in both treatment dose and effect. However, due to the inconsistency of reporting physiologic outcomes, it was unclear which of these parameters may provide the best clinical guidance in terms of both patient selection for PP and evaluation of treatment response. Other relevant data for example, relative changes in patients respiratory drive, dyspnoea scores and patient comfort were not consistently available. Given these limitations, the population that clearly stands to benefit from PP could not be clearly defined.

Although all patients demonstrated improved oxygenation, the patients with PaO 2 /FiO 2 ratio of ≤ 150 demonstrated a greater improvement. The reasons may possibly be that patients with more severe hypoxaemia had a greater degree of pulmonary vascular dysregulation and ventilation: those with perfusion mismatch to start with and benefited more with PP. However, such an interpretation is speculative and not much inference can be drawn from these data as an improved oxygenation with PP depends on several factors such as timing, duration, underlying pathophysiology and other respiratory supports used. For example, the duration of and frequency of prone ventilation were quite variable with some studies reporting a combination of lateral positioning and PP. Such variability is a concern when it comes to feasibility and generalisability of PP outside of centres that have some experience in PP of awake patients.

In addition, there was significant heterogeneity in oxygen therapies provided prior to and during PP. For example, 69% of the patients were receiving NIV and 12.6% were receiving oxygen via nasal cannula.

These two populations can be drastically different and may represent different stages of disease evolution. This is likely to have a significant bearing on adjunctive use of PP as essentially the outcomes depend on the success of combinations of these therapies. It should be noted that ARDS studies only tested PP in intubated patients enrolled patients with a PaO 2 /FiO 2 ≤ 150 to bring in some homogeneity in an otherwise heterogenous population of ARDS. In a recent network meta-analysis of trials of adult patients with acute . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. . hypoxaemic respiratory failure, 38 treatment with non-invasive oxygenation strategies compared with standard oxygen therapy was associated with lower risk of death. Most of the included studies predated the RECOVERY trial 39 and there was no consistent reporting on use of steroids or other disease modifying therapies limiting interpretation of the findings of the review.

Although there were no reported major adverse events following PP, not all included studies reported adverse events. Therefore, safety and efficacy of this intervention can only be tested in a well-designed randomised controlled trial and they are ongoing. 40 41 Placing critically ill, hypoxaemic, non-intubated patients in a prone position outside closely monitored units without ability to administer invasive mechanical ventilation when required may lead to poor outcomes. PP should be carefully undertaken in systems where this can be safely provided pending further evidence. Equally, PP may be considered as a useful adjunct in patients who are considered not suitable candidates for invasive mechanical ventilation while making sure their comfort and dignity is also prioritised.

In a selected group of patients who received PP, the incidence of intubation and mortality was relatively lower in comparison with a recent systematic review and meta-analysis on associations of non-invasive oxygenation strategies and all-cause mortality in COVID-19, which reported rates of 40% and 30% respectively. 38 In the absence of appropriate controls who did not receive PP for comparison, it is unclear whether these physiologic improvements resulted in reduced need for intubation or mortality. A noticeable difference was observed between the patients who had PP in ICU compared with other areas of the hospital both in terms of improvement in oxygenation and intubation rates. The oxygenation improvements were more marked in patients who underwent PP in ICU and there were corresponding lower intubation rates in ICU patients. However, a recent cohort study did not show any reduction in intubation rates or 28-day mortality in COVID-19 patients who received awake PP as an adjunctive therapy to HFNO. 42 It is possible that a selected patient population of non-intubated patients with COVID-19-related respiratory failure may benefit from PP. However, data available for this review was not of sufficient quality to identify the precise population that may benefit. Based on this review, PP appears feasible and safe in patients who are hypoxaemic and when undertaken in appropriately monitored environments.

Our study has some important limitations. This review was based on data from single arm observational case series and cohort studies that had no comparator groups. Consequently, heterogeneity and all the antecedent biases associated with patient selection and reporting was expected. The heterogeneity persisted despite sensitivity analyses were performed based on sample size. Given the inconsistent reporting of oxygenation parameters, we had to derive some of the variables from other reported variables and where possible requested missing data from the corresponding authors of the included studies.

Despite this, we still had missing variables in some of the included studies. This calls for a validated . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. . system to report changes in physiologic parameters in future studies that test respiratory supports in nonintubated patients. Healthcare worker infection risks and rates while assisting/facilitating PP were not reported in any of the studies. In addition, strong conclusions cannot be reached due to several factors:

first, the absence of tested, established triggers and a standardised process for initiating PP in nonintubated COVID-19 patients; second, the significant heterogeneity in the patient populations included and lack of granular data on co-interventions used (NIV, HFNC, Steroids, Antiviral therapies etc.); third, an absence of standardised intubation criteria; and, fourth, that the intervention was provided in some instances under pandemic stressors that affected resource availability.

There was a variable but significant improvement in oxygenation parameters with PP in non-intubated, hypoxic adult patients with COVID-19-related hypoxaemia. This review observed a lack of a standardised process for PP in non-intubated patients. Significant heterogeneity, inconsistent reporting, poor data quality and potential biases in data may affect the analysis. Absence of standardised intubation criteria and the provision of the intervention under pandemic stressors further limit interpretation. Well designed, randomised control studies testing the efficacy of PP in non-intubated COVID-19 patients are needed prior to widespread adoption of this practice.

We thank authors of all the studies for providing us with the data needed for our systematic review and meta-analysis. We are also grateful to Dr. Ata Mahmoodpoor, Dr. Xu Q, Dr. Tom Lawton, Dr. Caputo for responding to our request for additional information used in this study. Prof Shekar acknowledges the Metro North Hospital and Health Service for research support. Table 1 : 15 studies included in this systematic review and meta-analysis. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. . Figure 1 : Sensitivity analysis to minimise heterogeneity for PaO 2 /FiO 2 based on study sample size. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. . n* -number of awake prone positioned patients in the study ^ PP in 1 of the 10 patients happened in medical ward following ICU consultation and supervision NRB -Non-rebreather mask, hrs -hours; NC -Nasal cannula, HFNC -High-flow nasal cannula, VM -Venturi Mask / Hudson Mask, NIV -Non-invasive ventilation, EDemergency department, ICU -intensive care unit, HDU -high dependency unit, PP -prone positioning, D -the parameter was derived from other reported values, NR -the parameter was not reported in the study, + -the parameter was reported, 0 -no events.

.

It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. . is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted October 14, 2020. .

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease

Early Self-Proning in Awake, Non-intubated Patients in the Emergency Department: A Single ED's Experience During the COVID-19 Pandemic

Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations

Rate of Intensive Care Unit admission and outcomes among patients with coronavirus: A systematic review and Meta-analysis

Prone Positioning in Awake, Nonintubated Patients With COVID-19: Necessity Is the Mother of Invention

Prone position for acute respiratory failure in adults

Prone positioning improves oxygenation in spontaneously breathing nonintubated patients with hypoxemic acute respiratory failure: A retrospective study

Prone positioning in non-intubated patients with COVID-19: raising the bar

Efficacy of early prone position for COVID-19 patients with severe hypoxia: a single-center prospective cohort study

Prone positioning combined with high-flow nasal or conventional oxygen therapy in severe Covid-19 patients

Alternatives to Invasive Ventilation in the COVID-19 Pandemic

Relationship between gas exchange response to prone position and lung recruitability during acute respiratory failure

Prone position improves mechanics and alveolar ventilation in acute respiratory distress syndrome

COVID-19 Does Not Lead to a "Typical

Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement

COAP Living Evidence on COVID-19

Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barre syndrome: From systematic review to living systematic review

Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal

The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses Ottawa2013

Methodological quality of case series studies

Correlation between the levels of SpO2and PaO2

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

Metaprop: a Stata command to perform meta-analysis of binomial data

Measuring inconsistency in meta-analyses

Bias in meta-analysis detected by a simple, graphical test

Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study

Prone Positioning of Non-Intubated Patients with COVID-19

Reduced ICU demand with early CPAP and proning in COVID-19 at Bradford: a single centre cohort

Early awake prone position combined with high-flow nasal oxygen therapy in severe COVID-19: a case series

Prone positioning in high-flow nasal cannula for COVID-19 patients with severe hypoxemia: a pilot study

Prone Positioning in Awake, Nonintubated Patients With COVID-19 Hypoxemic Respiratory Failure

Respiratory Parameters in Patients With COVID-19 After Using Noninvasive Ventilation in the Prone Position Outside the Intensive Care Unit

Prone and Lateral Positioning in Spontaneously Breathing Patients With COVID-19 Pneumonia Undergoing Noninvasive Helmet CPAP Treatment

Prone positioning in management of COVID-19 hospitalized patients

Early application of prone position for management of Covid-19 patients

Use of Prone Positioning in Nonintubated Patients With COVID-19 and Hypoxemic Acute Respiratory Failure

Early Awake Prone and Lateral Position in Non-intubated Severe and Critical Patients with COVID-19 in Wuhan: A Respective Cohort Study

Association of Noninvasive Oxygenation Strategies With All-Cause Mortality in Adults With Acute Hypoxemic Respiratory Failure: A Systematic Review and Meta-analysis

Dexamethasone in Hospitalized Patients with Covid-19 -Preliminary Report

COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss (COVAYDE). In: (US) NLoM

Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE (APPROVE-CARE)

Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow nasal oxygen therapy: a multicenter, adjusted cohort study